Vaccines for malaria and dengue may hit Indian market in 2-4 years

There are several candidates in the works - the Serum Institute of India, Bharat Biotech, and Zydus Cadila are working on either developing or manufacturing anti-malarial vaccines

Vaccines for malaria and dengue, tropical mosquito-borne infections, could take two to four years to hit the Indian market, say industry insiders.

At present, there are several candidates in the works with the Serum Institute of India (SII), Bharat Biotech, and Zydus Cadila all working on either developing or manufacturing anti-malarial vaccines.

As for dengue, French firm Sanofi and Japan’s Takeda are looking to bring their vaccines here.

SII, the world’s largest vaccine maker, and Novavax are collaborating for phase-3 clinical trials of the Oxford University’s Jenner Institute’s malaria vaccine on over 4,800 children in four African countries. It has